SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019480
Filing Date
2021-08-11
Accepted
2021-08-11 16:31:48
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20210630_10q.htm   iXBRL 10-Q 731840
2 EXHIBIT 31.1 ex_272544.htm EX-31.1 13104
3 EXHIBIT 31.2 ex_272545.htm EX-31.2 13214
4 EXHIBIT 32.1 ex_272546.htm EX-32.1 4778
5 EXHIBIT 32.2 ex_272547.htm EX-32.2 4933
11 dm01.jpg GRAPHIC 36177
  Complete submission text file 0001437749-21-019480.txt   4028245

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20210630.xsd EX-101.SCH 44319
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20210630_cal.xml EX-101.CAL 32885
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20210630_def.xml EX-101.DEF 269239
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20210630_lab.xml EX-101.LAB 228028
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20210630_pre.xml EX-101.PRE 294130
12 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20210630_10q_htm.xml XML 559669
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 211163880
SIC: 2834 Pharmaceutical Preparations